This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.81% per year. These returns cover a period from January 1, 1988 through September 1, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
VOYA Stock Trading at a Discount to Industry at 1.12X: Time to Buy?
by Zacks Equity Research
Voya Financial is well-positioned for sustainable earnings growth, disciplined capital deployment and enhanced shareholder value, aided by strong operational execution.
Can Manulife's Organic Growth Power Long-Term Momentum Ahead?
by Zacks Equity Research
MFC leverages organic growth, acquisitions, and expansion in Asia to boost scale, diversify its offerings, and strengthen returns.
Trupanion Grows in Pet Insurance Amid Rising Veterinary Care Costs
by Zacks Equity Research
Trupanion rides on strong retention, new products and global expansion to boost revenues and outpace its industry peers.
BHF Outperforms Industry, Trades at a Discount: How to Play the Stock
by Zacks Equity Research
Brighthouse Financial stock gains on the back of higher annuity and life insurance sales, a high-quality portfolio, financial flexibility and prudent capital deployment.
Reinsurance Group Trades Below 50-Day SMA: How to Play the Stock?
by Zacks Equity Research
RGA's diversified growth, strong investment income and rising dividends contrast with debt-driven margin pressures.
SLF Stock Near 52-Week High: A Signal for Investors to Hold Tight?
by Zacks Equity Research
Sun Life Financial stock gains from growing asset management businesses, its focus on Asia operations, as well as scaling up and integrating U.S. operations.
MFC Outperforms Industry, Trades Near 52-Week High: Time to Hold?
by Zacks Equity Research
Manulife Financial stock rallies on the back of a solid Asia business, an expanding Wealth and Asset Management business and a strong capital position.
Reinsurance Group Stock Plunges 11.1% YTD: How Should You Play?
by Zacks Equity Research
RGA sees strong investment income growth, but higher costs, debt, and weaker ROE weigh on shares.
VOYA Stock Trading at a Discount to Industry at 1.11X: Time to Buy?
by Zacks Equity Research
Voya Financial shares trade at a notable discount, with a 1.11X price-to-book ratio well below industry, sector, and S&P 500 levels.
SLF Rallies 18% YTD, Trades at Premium: Should You Buy the Stock?
by Zacks Equity Research
Sun Life's global expansion through targeted deals boosts U.S. dental leadership, Asia reach, and asset management capabilities.
Brighthouse Financial Q2 Earnings Miss Estimates on Lower Premiums
by Zacks Equity Research
BHF posts Q2 earnings drop on lower premiums and investment income, despite a sharp cut in total expenses.
Sun Life Q2 Earnings Match Estimates, Revenues Increase Y/Y
by Zacks Equity Research
SLF's second-quarter results reflect record underlying net income in Asia with strong protection business growth, higher wealth management and investment earnings.
Manulife Q2 Earnings Miss Estimates, APE Sales Rise Y/Y
by Zacks Equity Research
MFC Q2 results reflect strong business growth in Global WAM, Asia, and Canada, offset by unfavorable life insurance claims experience in the United States.
Reinsurance Group Q2 Earnings and Revenues Miss, Premiums Rise Y/Y
by Zacks Equity Research
RGA misses Q2 earnings and revenue estimates as adjusted operating EPS and net income decline year over year.
Why Reinsurance Group (RGA) is a Great Dividend Stock Right Now
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Reinsurance Group (RGA) have what it takes? Let's find out.
Reinsurance Group (RGA) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates
by Zacks Equity Research
While the top- and bottom-line numbers for Reinsurance Group (RGA) give a sense of how the business performed in the quarter ended June 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Reinsurance Group (RGA) Q2 Earnings and Revenues Lag Estimates
by Zacks Equity Research
Reinsurance Group (RGA) delivered earnings and revenue surprises of -15.41% and -1.09%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
The Baldwin Insurance Group (BWIN) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
The Baldwin Insurance Group (BWIN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Exploring Analyst Estimates for Reinsurance Group (RGA) Q2 Earnings, Beyond Revenue and EPS
by Zacks Equity Research
Looking beyond Wall Street's top-and-bottom-line estimate forecasts for Reinsurance Group (RGA), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended June 2025.
Reinsurance Group (RGA) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Reinsurance Group (RGA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Here's Why Reinsurance Group (RGA) is a Strong Growth Stock
by Zacks Equity Research
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
SLF Outperforms Industry, Trades at a Premium: How to Play the Stock
by Zacks Equity Research
Sun Life expands in Asia's high-growth markets while shifting to capital-light products to boost returns and cut volatility.
Manulife Financial Stock Near 52-Week High: What Should Investors Do?
by Zacks Equity Research
MFC stock rallies on the back of solid Asia business, expanding Wealth and Asset Management business and strong capital position.
Here's Why Reinsurance Group (RGA) is a Strong Growth Stock
by Zacks Equity Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
RGA Stock Trading at Discount to Industry at 1.14X: Time to Hold?
by Zacks Equity Research
Reinsurance Group stock is poised to gain from new business volumes, favorable longevity experience, a diversified business, effective capital deployment and higher return on capital.